Investorideas.com - #Cannabis Industry to Benefit From Fresh Innovation as BIG Industry Show Heads to Los Angeles This August 30-31
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Monday, July 30, 2018
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: $OGI.V, TSX: $ACB.TO, TSXV: $ALEF.V, TSXV: $EMH.V
Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move: TSXV: $OGI.V,
TSX: $ACB.TO, TSXV: $ALEF.V, TSXV: $EMH.V
July 30th Potcast
sponsored by Lexaria Bioscience Corp. ( CSE: $LXX.C ) (OTC: $LXRP) a #Cannabis
company with a new disruptive drug delivery platform: DehydraTECH
Delta, Kelowna, BC –July 30, 2018 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/07303Potcasts-TSXV-OGI-ACB-ALEF-EMH.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast – looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on
the OTC as LXRP. Lexaria has developed a new disruptive
drug delivery platform: DehydraTECH The Company’s patented technology changes
the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120
min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple
APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal
anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble
vitamins.
Today’s podcast features news from Organigram Holdings Inc( TSX-VENTURE: OGI and OTCQB: OGRMF), Aurora Cannabis Inc. (TSX: ACB and OTCQB: ACBFF), Aleafia Health Inc. (TSX-VENTURE: ALEF) , Emerald Health
Therapeutics, Inc. (TSX-VENTURE: EMH) and Village Farms
International, Inc. (TSX : VFF and OTC: VFFIF) .
Organigram Holdings Inc., the parent company of Organigram Inc., a
leading licensed producer of medical marijuana based in Moncton, New Brunswick,
announced its financial results for the three and nine-months ended May 31,
2018.
Some of the operational highlights include:
·
Organigram began harvesting from its Phase 2 expansion facility (23 grow
rooms) on April 20, 2018 bringing its target production of dried flower
equivalent to 22,000 kg/annum;
·
In May the Company launched its adult recreational brand strategy which
included house brands such as The
Edison Cannabis Company, ANKR
Organics and Trailer
Park Buds;
·
In May Organigram received a "License for Controlled Drugs and
Substances" from Health Canada making the Company a Licensed Dealer;
·
In May the Company received its "Permit to Export Cannabis"
license which allowed Organigram the ability to make its first international
medical shipment to Australia (completed in July);
·
Shortly after quarter-end the Company began use of its Phase 3 expansion
filling six of the 16 grow rooms with the remaining rooms filled in June and
July bringing its target production of dried flower equivalent to 36,000
kg/annum; and
·
Announced strategic investments in: Hyasynth Biologicals, Alpha-Cannabis
Germany, and Eviana (see previous press releases for more details) which all
are expected to close in the calendar third quarter.
Some of the financial highlights included:
·
Record net sales for both the three-months and nine-months ended May 31,
2018 of $3.7 million and $10.1 million respectively vs. $1.9 million and $3.6
million respectively for 2017;
·
Record sale volume of cannabis oil for the three-months ended May 31,
2018 (768,400 milliliters) up 39% from Q2/18 (552,250) and up 452% from Q3/17
(139,200 milliliters);
·
Record sales volume of dried flower (303,428 grams) for the three-months
ended up 28% from Q2/18 (237,650 grams) and up 55% from Q3/17 (196,129 grams);
·
Record yields per plant in the quarter ended May 31, 2018 (see MD&A
for further details);
·
Cost of cultivation per gram of dried flower harvested of $0.80 per gram
"all-in" (direct labour and materials, allocated overhead and
depreciation) and $0.58/gram excluding depreciation. Note that cost of
cultivation is a non-GAAP measure used by management internally and does not
include indirect production, packaging or shipping costs (see financial
statements and MD&A for further details);
·
Registered medical patients climbed to a record 15,316 by the end of Q3
up 18% since Q2 (12,957);
·
Impairment of goodwill on its 2017 acquisition of Trauma Healing Centres
in the amount of $1.2 million related to "right sizing" of the
business opportunity;
·
Net interest expense of $3.7 million for the quarter primarily
attributable to the interest expense on $115 million of convertible debentures
issued on January 31, 2018; and
·
Net income of $2.8 million, an increase of 162% compared to $1.1 million
in Q2-2018 and a loss of $2.3 million in Q3-2017.
Aurora Cannabis Inc. today announced that it has
obtained a Health Canada Dealer's License ("Dealer's License") under
the Controlled Drugs and Substances
Act for its EU GMP certified Aurora Mountain facility in Alberta. The
new license will allow Aurora additional opportunities to produce, assemble,
and sell cannabis oils and future novel, derivative products from Aurora
Mountain, Furthermore, the license provides additional opportunities to
transport cannabis products for import from and export to international
markets, subject to applicable regulations.
A dealer's license is also critical for expanding research and
development capacity as it provides the potential for working with cannabinoids
and their derivatives not covered under an ACMPR license. This will enable
Aurora and its subsidiaries to drive innovation in the form of marketable
intellectual property, and new value-added products.
Aleafia Health Inc., one of Canada's leading, vertically
integrated medical cannabis companies with a unique patient-focused, healthcare
solution, announced that it has closed its previously announced acquisition of
a modern, fully automated 160,000 sq. ft. greenhouse in the Niagara Region.
Renovations at the facility are already underway, with the facility
expected to be retrofitted and licensed before the end of 2018, with a first
harvest expected in spring 2019. The facility will join Aleafia's existing
licenced facility in Scugog, Ontario, which is expected to undergo a 150,000
sq. ft. expansion.
Emerald Health Therapeutics, Inc. and Village Farms International, Inc.
today announced that their 50/50 joint venture for large-scale, low-cost,
high-quality cannabis production, Pure Sunfarms, has received its cannabis
sales license from Health Canada. Pure Sunfarms is now permitted to immediately
begin selling product from its expanding inventory of high-quality dried
cannabis, including to Emerald Health Therapeutics, under their previously
announced supply agreement, as well as to address significant demand from other
licensed producers. This sales license also positions Pure Sunfarms to secure
supply agreements with provincial government distributors for the imminent legal
adult-use marketplace.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Lexaria Bioscience Corp. has developed and
out-licenses its disruptive delivery technology that promotes healthier
ingestion methods, lower overall dosing and higher effectiveness of lipophilic
active molecules. Lexaria has multiple patents pending in over 40 countries
around the world and has patents granted in the USA and in Australia for
utilization of its DehydraTECHTM delivery technology. Lexaria's technology
provides increases in intestinal absorption rates; more rapid delivery to the
bloodstream; and important taste-masking benefits, for orally administered
bioactive molecules including cannabinoids, vitamins, non-steroidal
anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music,
Stitcher iHeartradio and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock
directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis
Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria
Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast
starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with Sedar.
Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Do you trade or invest in Marijuana / Hemp Stocks? Check out our stock directory of publicly
traded CSE, TSX, TSXV, OTC, NASDAQ,
NYSE, ASX Marijuana / Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing
Friday, July 27, 2018
InvestorIdeas & Stock Analyst Guru - Support and Resistance Trading Ep4 ...
www.investorideas.com - News that inspires big Ideas
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: AB...
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investorideas.com - #Cannabisstocks: Canada Coal (TSX-V:CCK) Announces Proposed Reverse Takeover Transaction of Medcolcanna S.A.S.
Investorideas.com - #Cannabisstocks: Canada Coal (TSX-V:CCK) Announces Proposed Reverse Takeover Transaction of Medcolcanna S.A.S.
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Subscribe to:
Posts (Atom)